Tools
Tools
Hasselgren, C, Ahlberg, E, Akahori, Y, Amberg, A, Anger, L, Atienzar, F, Auerbach, S, Beilke, L, Bellion, P, Benigni, R, Bercu, J, Booth, E, Bower, D, Brigo, A, Cammerer, Z, Cronin, MTD, Crooks, I, Cross, K, Custer, L, Dobo, K , Doktorova, TY, Faulkner, D, Ford, DA, Fortin, MC, Frericks, M, Gad-McDonald, SE, Gellatly, N, Gerets, H, Gervais, V, Glowienke, S, van Gompel, J, Harvey, JS, Hillegass, J, Honma, M, Hsieh, JH, Hsu, CW, Barton-Maclaren, TS, Johnson, C, Jolly, R, Jones, D, Kemper, R, Kenyon, MO, Kruhlak, NL, Kulkarni, SA, Kümmerer, K, Leavitt, P, Maston, S, Miller, S, Moudgal, C, Muster, W, Paulino, A, Piparo, EL, Powley, M, Quigley, DP, Reddy, MV, Richarz, AN, Schilter, B, Snyder, RD, Stavitskaya, L, Stidl, R, Szabo, DT, Teasdale, A, Tice, RR, Trejo-Martin, A, Vuorinen, A, Wall, BA, Watts, P, White, AT, Wichard, J, Witt, KL, Woolley, A, Woolley, D, Zwickl, C and Myatt, GJ (2019) Genetic toxicology in silico protocol. Regulatory Toxicology and Pharmacology. ISSN 0273-2300
Full text not available from this repository. Please see publisher or open access link below:Abstract
In silico toxicology (IST) approaches to rapidly assess chemical hazard, and usage of such methods is increasing in all applications but especially for regulatory submissions, such as for assessing chemicals under REACH as well as the ICH M7 guideline for drug impurities. There are a number of obstacles to performing an IST assessment, including uncertainty in how such an assessment and associated expert review should be performed or what is fit for purpose, as well as a lack of confidence that the results will be accepted by colleagues, collaborators and regulatory authorities. To address this, a project to develop a series of IST protocols for different hazard endpoints has been initiated and this paper describes the genetic toxicity in silico (GIST) protocol. The protocol outlines a hazard assessment framework including key effects/mechanisms and their relationships to endpoints such as gene mutation and clastogenicity. IST models and data are reviewed that support the assessment of these effects/mechanisms along with defined approaches for combining the information and evaluating the confidence in the assessment. This protocol has been developed through a consortium of toxicologists, computational scientists, and regulatory scientists across several industries to support the implementation and acceptance of in silico approaches.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 1115 Pharmacology and Pharmaceutical Sciences |
| Subjects: | Q Science > QH Natural history > QH426 Genetics R Medicine > RS Pharmacy and materia medica |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Elsevier |
| Date Deposited: | 18 Jun 2019 09:44 |
| Last Modified: | 03 Sep 2021 22:52 |
| DOI or ID number: | 10.1016/j.yrtph.2019.104403 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/10906 |
 |
View Item |